Jessica Walsh, MD
Enriched profileAssociate Professor of Rheumatology, University of Utah and Salt Lake City Veterans Affairs Health · Salt Lake City Veterans Affairs Health & University of Utah Health
Jessica Walsh is Associate Professor of Rheumatology, University of Utah and Salt Lake City Veterans Affairs Health at Salt Lake City Veterans Affairs Health & University of Utah Health. OpenAlex indexes 172 publications with 3,241 citations (h-index 28); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jessica Ann Walsh, MD, is Associate Professor of Rheumatology, University of Utah and Salt Lake City Veterans Affairs Health at Salt Lake City Veterans Affairs Health & University of Utah Health. The public record shows 172 publications with 3,241 citations (h-index 28), centered on Psoriasis / Psoriatic Arthritis. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 12 companies, 1 NIH-funded awards (2026–2026).
- Most recent indexed publication: 2026 · Arthritis care & research
- Top research focus: Psoriasis / Psoriatic Arthritis
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Sponsor: University of Pennsylvania
- Psoriatic Arthritis D2P Screening
Sponsor: Jessica Walsh
Industry payments
Updated 27 Aug 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year202510 payments
- ABBVIE INC.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
82.6%TNF inhibitor28.4%Humira(Cf) Pen55%Enbrel Sureclick46%Part D<11 patientsFolate Analog Metabolic Inhibitor23.2%Methotrexate100%Part D≥15 patientsNervous system
9%Nonsteroidal Anti-inflammatory Drug9%Meloxicam100%Part D<11 patientsMetabolism & gastrointestinal
8.4%Antidiarrheal microorganisms8.4%Folic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Neural mechanisms underlying sustained enhancement of sociability
Univ of North Carolina Chapel Hill
FY2026$750,391R01MH136266 - Screening Electronic Records for Veterans whoshould be referred for specialty care Evaluations(SERVE)
Va Salt Lake City Healthcare System
FY2026I01HX003705 - Neural mechanisms underlying sustained enhancement of sociability
Univ of North Carolina Chapel Hill
FY2025$757,901R01MH136266
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Mortality in US Veterans With Rheumatoid Arthritis Treated With Immune Checkpoint Inhibitors.
Arthritis care & research
Article2026 - Immune Checkpoint Inhibitor-Related Myositis and Associated Triad Overlap Syndrome.
Arthritis care & research
Article2026 - Sustained improvements in health status and work productivity with bimekizumab in psoriatic arthritis: 2-year results from two phase 3 studies.
Rheumatology advances in practice
Article2026 - COVID-19 Vaccination Is Not Associated With the Development of Idiopathic Inflammatory Myositis in US Veterans.
Arthritis care & research
Article2025 - World Café Report From the GRAPPA 2024 Annual Meeting and Trainee Symposium: Exploring GRAPPA's Future Priorities.
The Journal of rheumatology
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jessica-walsh-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- MD
MBA, MSCI, University of Utah
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthcare.utah.edu ↗ - Board Certified
Internal Medicine and Rheumatology (ABIM)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthcare.utah.edu ↗
Editorial & leadership roles
journal and society appointments- Member
National Psoriasis Foundation (NPF); patient advocacy leadership recognized at 2026 NPF Gala
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasis.org ↗ - Contributor
World Café Report from the GRAPPA 2024 Annual Meeting and Trainee Symposium, The Journal of Rheumatology
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jrheum.org ↗ - Director
Utah Psoriatic Arthritis Program / Spondyloarthritis Clinic, University of Utah
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasis.org ↗
Awards & honors
honors on the public record- 2026 National Gala Honoree
National Psoriasis Foundation, recognized at the Commit to Cure Gala (Salt Lake City, April 11 …
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasis.org ↗ - Young Investigator Award
Spondylitis Association of America (SAA), $20,000 award, reported Feb 2016 while an Instructor at University of Utah School of Medicine/George E. Wahlen VA Medical Center
2016provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.utah.edu ↗
Secondary affiliations
appointments beyond the home institution- George E. Wahlen Veterans Affairs Medical Center
Salt Lake City
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthcare.utah.edu ↗
Media & interviews
press, podcasts and appearances- "Understanding Psoriatic Arthritis: Signs Symptoms Treatments"
YouTube educational video co-featuring Jessica Walsh, MD (Univ. of Utah) and Alexis Ogdie, MD (Univ. of Pennsylvania), published Aug 2019
2019provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Keynote speaker
National Psoriasis Foundation and Spondyloarthritis Association of America events on psoriatic arthritis/axial spondyloarthritis
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthcare.utah.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University